Clinical Trial Update: A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 trial comparing two versions of topotecan to determine if they have the same potency in patients with advanced solid tumors. The study includes small ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Topotecan (Hycamtin) (Topotecan)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lung Cancer, Small Cell | Phase 1 | Status: COMPLETED